Global Breast Cancer Monoclonal Antibodies Market to post a revenue of 13.7 billion by 2020

MarketResearchReports.Biz has announced addition of new report “Global Breast Cancer Monoclonal Antibodies Market 2016-2020” to its database.

About Breast Cancer mAbs

Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates the growth and division of malignant cells. Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific, as they are the clones of a single parent cell.

Technavios analysts forecast the global breast cancer monoclonal antibodies (mAbs) market to post a revenue of 13.7 billion by 2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global breast cancer monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of branded mAbs and biosimilars used to treat breast cancer.

The market is divided into the following segments based on geography:




Technavio’s report, Global Breast Cancer Monoclonal Antibodies (mAbs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Sample Copy of Report at

Key vendors





Other prominent vendors

Array BioPharma



Boehringer Ingelheim

Bristol-Myers Squibb

Celldex Therapeutics


Chugai Pharmaceutical

Daiichi Sankyo

DARA Biosciences



Galena Biopharma


Halozyme Therapeutics










Puma Biotechnology

Seattle Genetics

Sun Pharmaceutical Industries

Synta Pharmaceuticals

Teva Pharmaceuticals


Market driver

Reimbursement benefits for breast cancer mAbs

For a full, detailed list, view our report


Market challenge

Absence of adequate diagnosis and screening procedures for early detection

For a full, detailed list, view our report


Market trend

Emergence of targeted and combination therapies for breast cancer

For a full, detailed list, view our report


Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?


About Us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Latest Industry Press Release


Contact Us

State Tower

90 State Street, Suite 700

Albany, NY 12207

United States

Tel: +1-518-621-2074



Follow us on LinkedIn:


%d bloggers like this: